Lai, Qiu-yu
He, Ying-zhi
Peng, Xiong-wen
Zhou, Xuan
Liang, Dan
Wang, Liang
Funding for this research was provided by:
Pearl River Nova Program of Guangzhou (201710010161)
Article History
Received: 25 February 2019
Accepted: 15 July 2019
First Online: 29 July 2019
Ethics approval and consent to participate
: The experimental protocols were approved by the ethics committee of ZhuJiang Hospital of Southern Medical Univeristy.
: Bone marrow samples were obtained from five AML patients with refractory disease and five AML patients in remission after they had signed informed consent forms.
: The authors declare that they have no competing interests.